Star Imaging and Path Lab Limited is an India-based company, which is primarily engaged in operating pathology and diagnostic centers in New Delhi and Uttar Pradesh. The Company offers a comprehensive range of diagnostic imaging services and clinical laboratory tests, including both routine and specialized studies and profiles. These services are essential for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its diagnostic imaging and radiology services encompass X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry, and mammography. In the pathology segment, its services include biochemistry, hematology, clinical pathology, histopathology, cytopathology, microbiology, serology, and immunology. Its specialized diagnostic tests cover a wide spectrum of advanced techniques, requiring skilled personnel, precision equipment, and sophisticated technology.As of 25 May 2026, STAR IMAGING AND PATH LAB LIMI share price is ₹76.75. The stock opened at ₹69.45, compared to its previous close of ₹73.10. During today's trading session, STAR IMAGING AND PATH LAB LIMI share price moved in the range of ₹69.45 to ₹76.75, with an average price of ₹73.10 for the day. Looking at its last 52-week, the stock has touched a low of ₹69.45 and a high of ₹76.75.
The market capitalization of STAR IMAGING AND PATH LAB LIMI is ₹0 Cr, with a P/E ratio of 8.0 and a dividend yield of 0.00%.